GlassScriptPhysician profile
Adam Young
NPI 1841855624
$1,268.43
in general payments reported to CMS, 2019-2025
18 companies · $412 in 2025
The $412 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $527 · 2024: $329 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $209.26 | 2023 | Lynparza |
| Biogen, INC. | $163.45 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $158.15 | 2023-2025 | Lo Loestrin Fe |
| Pfizer INC. | $142.21 | 2024 | |
| Ethicon US, LLC | $106.69 | 2025 | Enseal, Harmonic |
| Glaxosmithkline, LLC. | $75.76 | 2023 | Zejula |
| Myriad Women'S Health, INC. | $75.57 | 2023 | Myrisk |
| Astellas Pharma US INC | $70.78 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $52.31 | 2023-2025 | Myfembree |
| Organon LLC | $44.71 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $30.89 | 2023 | Lynparza, Keytruda |
| Mayne Pharma Commercial LLC | $28.98 | 2023 | |
| Seagen INC. | $21.34 | 2023 | Tivdak |
| Amgen INC. | $21.25 | 2024 | Prolia, Evenity |
| Medtronic, INC. | $19.13 | 2023 | Rapidvac |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.83 | 2023 | Mara Console |
| Convatec INC. | $16.17 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.